FDA clinical trial: Myopia study shows benefits of wavefront-guided ablations


Orlando-Six-month results from an FDA clinical trial indicate that customized wavefront-guided LASIK for treatment of myopia with the WavePrint system (VISX) is associated with safe and effective outcomes exceeding FDA targets. The wavefront-guided LASIK is also effective for minimizing increases in higher-order aberrations that can accompany conventional LASIK.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.